Advik Laboratories’ rights issue stayed by Delhi High Court

Delhi's Patiala House Court has stayed Advik Laboratories' proposed rights issue following a petition by shareholder Fairplan Distributors Pvt. Ltd., which alleged corporate governance lapses and concerns over utilisation of funds from previous capital raises. The court granted an ad-interim ex parte injunction, restraining the company from regulatory filings, circulation of offer documents, acceptance of subscriptions, and allotment of shares. The matter is scheduled for further hearing on August 22, 2026, while Advik Laboratories shares were flat at about ₹1.81 apiece on the BSE.